Patents by Inventor George Tidmarsh

George Tidmarsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Unit dose form for administration of ibuprofen
    Publication number: 20080020040
    Abstract: An oral dosage form for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine, in separate compartments, in amounts suitable for three times per day administration.
    Type: Application
    Filed: July 18, 2006
    Publication date: January 24, 2008
    Applicant: Horizon Therapeutics, Inc.
    Inventors: George Tidmarsh, Barry L. Golombik, Puneet Sharma
  • Methods and medicaments for administration of ibuprofen
    Publication number: 20080021078
    Abstract: A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine, in separate compartments, is administered three times per day.
    Type: Application
    Filed: July 18, 2006
    Publication date: January 24, 2008
    Applicant: Horizon Therapeutics, Inc.
    Inventors: George Tidmarsh, Barry L. Golombik, Puneet Sharma
  • Unit dose form with ibuprofen-famotidine admixture
    Publication number: 20070043096
    Abstract: An oral dosage form for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine, in admixture, in amounts suitable for three times per day administration.
    Type: Application
    Filed: July 18, 2006
    Publication date: February 22, 2007
    Applicant: Horizon Therapeutics, Inc.
    Inventors: George Tidmarsh, Barry Golombik, Tianshiuan Lii
  • Medicaments containing famotidine and ibuprofen and administration of same
    Publication number: 20070043097
    Abstract: A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine, in admixture, is administered three times per day.
    Type: Application
    Filed: July 18, 2006
    Publication date: February 22, 2007
    Applicant: Horizon Therapeutics, Inc.
    Inventors: George Tidmarsh, Barry Golombik, Tianshiuan Lii
  • Combination therapies for the treatment of cancer
    Publication number: 20060276527
    Abstract: Lonidamine or a lonidamine analog is administered with one or more additional anti-cancer agents or surgery or radiation to treat cancer or is administered alone or in combination to treat cancer, optionally in a sustained release formulation, and improve patient outcome.
    Type: Application
    Filed: January 16, 2004
    Publication date: December 7, 2006
    Applicant: Thresold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
    Publication number: 20060172305
    Abstract: The level of one or more glucose transporters in a sample containing cancer cells is measured and compared to a reference value to determine whether the cancer is susceptible to treatment with an anti-cancer agent comprising glucose or glucose analog that is transported into the cancer by a glucose transporter.
    Type: Application
    Filed: March 4, 2004
    Publication date: August 3, 2006
    Inventor: George Tidmarsh
  • Treatment of benign prostatic hyperplasia using energolytic agents
    Publication number: 20060172953
    Abstract: The invention provides a method for treatment or prophylaxis of benign prostatic hyperplasia by administration of an agent that interferes with energy metabolism, particularly the production of ATP and NADH/NADPH, in prostate epithelial cells.
    Type: Application
    Filed: January 16, 2004
    Publication date: August 3, 2006
    Applicant: Threshold Pharmaceuticals Inc.
    Inventors: George Tidmarsh, Harold Selick
  • Methods for cancer imaging
    Publication number: 20060165597
    Abstract: Methods are provided for cancer and pre-cancer detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells.
    Type: Application
    Filed: November 30, 2005
    Publication date: July 27, 2006
    Applicant: Threshold Pharmaceutical, Inc.
    Inventors: George Tidmarsh, Mark Matteucci
  • Compositions and methods for treating cancer
    Publication number: 20060142207
    Abstract: Methods and compositions are provided for the treatment of cancer that take advantage of the increased uptake of glucose-anti-neoplastic agent conjugates in cancer cells relative to normal cells.
    Type: Application
    Filed: December 1, 2005
    Publication date: June 29, 2006
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventors: George Tidmarsh, Mark Matteuccii, Photon Rao
  • Compositions and methods for treating cancer
    Patent number: 7001888
    Abstract: Methods and compositions are provided for the treatment of cancer that take advantage of the increased uptake of glucose-anti-neoplastic agent conjugates in cancer cells relative to normal cells.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: February 21, 2006
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventors: George Tidmarsh, Mark Matteucci, Photon Rao
  • Treatment of benign prostatic hyperplasia
    Patent number: 6989400
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: January 24, 2006
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Methods for cancer imaging
    Patent number: 6989140
    Abstract: Methods are provided for cancer and pre-cancer detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: January 24, 2006
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventors: George Tidmarsh, Mark Matteucci
  • Treatment of cancer with 2-deoxyglucose
    Patent number: 6979675
    Abstract: The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: December 27, 2005
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Prevention and treatment of benign prostatic hyperplasia
    Publication number: 20050272795
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 8, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
    Publication number: 20050272796
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 8, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Dosage forms for treatment of benign prostatic hyperplasia
    Publication number: 20050271723
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidarrine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 8, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Treatment of cancer with 2-deoxyglucose
    Publication number: 20050245462
    Abstract: The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
    Type: Application
    Filed: June 30, 2005
    Publication date: November 3, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Treatment of benign prostatic hyperplasia
    Publication number: 20040167196
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: January 16, 2004
    Publication date: August 26, 2004
    Inventor: George Tidmarsh
  • Treatment of cancer with 2-deoxyglucose
    Publication number: 20040167079
    Abstract: The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
    Type: Application
    Filed: January 9, 2004
    Publication date: August 26, 2004
    Inventor: George Tidmarsh
  • Compositions and methods for treating cancer
    Publication number: 20040029815
    Abstract: Methods and compositions are provided for the treatment of cancer that take advantage of the increased uptake of glucose-anti-neoplastic agent conjugates in cancer cells relative to normal cells.
    Type: Application
    Filed: March 28, 2003
    Publication date: February 12, 2004
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventors: George Tidmarsh, Mark Matteucci, Photon Rao